全文获取类型
收费全文 | 139966篇 |
免费 | 12605篇 |
国内免费 | 1165篇 |
专业分类
耳鼻咽喉 | 583篇 |
儿科学 | 2796篇 |
妇产科学 | 2432篇 |
基础医学 | 8083篇 |
口腔科学 | 5574篇 |
临床医学 | 28702篇 |
内科学 | 11516篇 |
皮肤病学 | 1072篇 |
神经病学 | 6460篇 |
特种医学 | 1684篇 |
外科学 | 6821篇 |
综合类 | 18828篇 |
现状与发展 | 3篇 |
一般理论 | 119篇 |
预防医学 | 45047篇 |
眼科学 | 574篇 |
药学 | 7446篇 |
618篇 | |
中国医学 | 2629篇 |
肿瘤学 | 2749篇 |
出版年
2024年 | 495篇 |
2023年 | 3671篇 |
2022年 | 5225篇 |
2021年 | 7051篇 |
2020年 | 7189篇 |
2019年 | 6513篇 |
2018年 | 5938篇 |
2017年 | 5668篇 |
2016年 | 5475篇 |
2015年 | 5345篇 |
2014年 | 9879篇 |
2013年 | 11967篇 |
2012年 | 8954篇 |
2011年 | 9334篇 |
2010年 | 7253篇 |
2009年 | 6900篇 |
2008年 | 6785篇 |
2007年 | 7005篇 |
2006年 | 6094篇 |
2005年 | 4544篇 |
2004年 | 3773篇 |
2003年 | 3222篇 |
2002年 | 2433篇 |
2001年 | 2214篇 |
2000年 | 1902篇 |
1999年 | 1407篇 |
1998年 | 1170篇 |
1997年 | 913篇 |
1996年 | 777篇 |
1995年 | 601篇 |
1994年 | 528篇 |
1993年 | 488篇 |
1992年 | 388篇 |
1991年 | 377篇 |
1990年 | 320篇 |
1989年 | 261篇 |
1988年 | 286篇 |
1987年 | 201篇 |
1986年 | 162篇 |
1985年 | 191篇 |
1984年 | 133篇 |
1983年 | 82篇 |
1982年 | 83篇 |
1981年 | 98篇 |
1980年 | 84篇 |
1979年 | 64篇 |
1978年 | 58篇 |
1977年 | 61篇 |
1976年 | 64篇 |
1975年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
101.
102.
103.
Marie V. Plaisime PhD MPH Marie Jipguep-Akhtar PhD Joseph J. Locascio PhD Harolyn M. E. Belcher MD MHS Rachel R. Hardeman PhD MPH Katherine Picho-Kiroga PhD Sylvia P. Perry PhD Sean M. Phelan PhD MPH Michelle van Ryn PhD LMFT MPH John F. Dovidio PhD 《Health services research》2023,58(Z2):229-237
Objective
To examine the experience of interracial anxiety among health professionals and how it may affect the quality of their interactions with patients from racially marginalized populations. We explored the influence of prior interracial exposure—specifically through childhood neighborhoods, college student bodies, and friend groups—on interracial anxiety among medical students and residents. We also examined whether levels of interracial anxiety change from medical school through residency.Data Source
Web-based longitudinal survey data from the Medical Student Cognitive Habits and Growth Evaluation Study.Study Design
We used a retrospective longitudinal design with four observations for each trainee. The study population consisted of non-Black US medical trainees surveyed in their 1st and 4th years of medical school and 2nd and 3rd years of residency. Mixed effects longitudinal models were used to assess predictors of interracial anxiety and assess changes in interracial anxiety scores over time.Principal Findings
In total, 3155 non-Black medical trainees were followed for 7 years. Seventy-eight percent grew up in predominantly White neighborhoods. Living in predominantly White neighborhoods and having less racially diverse friends were associated with higher levels of interracial anxiety among medical trainees. Trainees' interracial anxiety scores did not substantially change over time; interracial anxiety was highest in the 1st year of medical school, lowest in the 4th year, and increased slightly during residency.Conclusions
Neighborhood and friend group composition had independent effects on interracial anxiety, indicating that premedical racial socialization may affect medical trainees' preparedness to interact effectively with diverse patient populations. Additionally, the lack of substantial change in interracial anxiety throughout medical training suggests the importance of providing curricular tools and structure (e.g., instituting interracial cooperative learning activities) to foster the development of healthy interracial relationships. 相似文献104.
Sierra Holland 《Sociology of health & illness》2019,41(1):52-66
Medical interactions around reproduction are increasingly extending beyond the physician's office and onto the Internet, where negotiation with medical authority occurs in complex and dynamic ways. Recently, scholars have noted the Internet's potential for creating spaces where women can dialogue with and reconstruct medical authority, yet this growing body of work is overwhelming heteronormative. This paper thus interrogates how lesbian women use the Internet to challenge, deploy, and rework medical authority around reproduction while navigating the transition to parenthood. I draw from 17 online journals authored by lesbian couples during the conception, pregnancy, and birth of their first child, each spanning between 18 months and 2 years, in order to understand how the transition process unfolds over time. I argue that lesbian couples engage with medical authority when seeking affirmation and normalisation yet discard and publicly reject the heteronormative assumptions that accompany reproductive medicine. Further, they chart a new process that I term ‘constructing queer mother‐knowledge’, in which they critique and balance knowledges from institutionalised medicine, their own bodies, and their queer communities. With this new concept, I complicate understandings of lesbian mothers‐to‐be and their interactions with medical authority as they build subversive families. 相似文献
105.
106.
107.
108.
109.
110.
《Value in health》2022,25(12):1958-1966
ObjectivesNational health technology assessments (HTAs) across Europe show differences in evidentiary requirements from assessments by the European Medicines Agency (EMA), affecting time to patient access for drugs after marketing authorization. This article analyzes the differences between EMA and HTA bodies’ evidentiary requirements for oncology drugs and provides recommendations on potential further alignment to minimize and optimally manage the remaining differences.MethodsInterviews were performed with representatives and drug assessment experts from EMA and HTA bodies to identify evidentiary requirements for several subdomains and collect recommendations for potentially more efficiently addressing differences. A comparative analysis of acceptability of the evidence by EMA and the HTA bodies and for potential further alignment between both authorities was conducted.ResultsAcceptability of available evidence was higher for EMA than HTA bodies. HTA bodies and EMA were aligned on evidentiary requirements in most cases. The subdomains showing notable differences concerned the acceptance of limitation of the target population and extrapolation of target populations, progression-free survival and (other) surrogate endpoints as outcomes, cross-over designs, short trial duration, and clinical relevance of the effect size. Recommendations for reducing or optimally managing differences included joint early dialogues, joint relative effectiveness assessments, and the use of managed entry agreements.ConclusionsDifferences between assessments of EMA and HTA bodies were identified in important areas of evidentiary requirements. Increased alignment between EMA and HTA bodies is suggested and recommendations for realization are discussed. 相似文献